These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18541389)

  • 21. A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.
    Schmitz JM; Green CE; Stotts AL; Lindsay JA; Rathnayaka NS; Grabowski J; Moeller FG
    Drug Alcohol Depend; 2014 Mar; 136():100-7. PubMed ID: 24424425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial.
    King A; Vena A; de Wit H; Grant JE; Cao D
    JAMA Netw Open; 2022 Mar; 5(3):e220951. PubMed ID: 35244704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT.
    Hajek P; Phillips-Waller A; Przulj D; Pesola F; Smith KM; Bisal N; Li J; Parrott S; Sasieni P; Dawkins L; Ross L; Goniewicz M; Wu Q; McRobbie HJ
    Health Technol Assess; 2019 Aug; 23(43):1-82. PubMed ID: 31434605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence.
    Kampman KM; Lynch KG; Pettinati HM; Spratt K; Wierzbicki MR; Dackis C; O'Brien CP
    Drug Alcohol Depend; 2015 Oct; 155():105-10. PubMed ID: 26320827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.
    Weinberger AH; Reutenauer EL; Jatlow PI; O'Malley SS; Potenza MN; George TP
    Drug Alcohol Depend; 2010 Mar; 107(2-3):188-95. PubMed ID: 19939587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study.
    Dunlop BW; Crits-Christoph P; Evans DL; Hirschowitz J; Solvason HB; Rickels K; Garlow SJ; Gallop RJ; Ninan PT
    J Clin Psychopharmacol; 2007 Dec; 27(6):614-9. PubMed ID: 18004129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modafinil: a useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies.
    Martínez-Raga J; Knecht C; Cepeda S
    Curr Drug Abuse Rev; 2008 Jun; 1(2):213-21. PubMed ID: 19630720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiety Sensitivity and Distress Tolerance in Smokers: Relations With Tobacco Dependence, Withdrawal, and Quitting Success†.
    Schlam TR; Baker TB; Smith SS; Cook JW; Piper ME
    Nicotine Tob Res; 2020 Jan; 22(1):58-65. PubMed ID: 31056710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.
    Winhusen TM; Somoza EC; Brigham GS; Liu DS; Green CA; Covey LS; Croghan IT; Adler LA; Weiss RD; Leimberger JD; Lewis DF; Dorer EM
    J Clin Psychiatry; 2010 Dec; 71(12):1680-8. PubMed ID: 20492837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
    Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
    Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.
    Piper ME; Cook JW; Schlam TR; Jorenby DE; Baker TB
    Addiction; 2011 Feb; 106(2):418-27. PubMed ID: 20973856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.
    Kalman D; Herz L; Monti P; Kahler CW; Mooney M; Rodrigues S; O'Connor K
    Drug Alcohol Depend; 2011 Nov; 118(2-3):111-8. PubMed ID: 21507585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
    Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
    JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
    Jones JD; Babalonis S; Marcus R; Vince B; Kelsh D; Lofwall MR; Fraser H; Paterson B; Martinez S; Martinez DM; Nunes EV; Walsh SL; Comer SD
    Addict Biol; 2020 Jul; 25(4):e12799. PubMed ID: 31240842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia.
    Pierre JM; Peloian JH; Wirshing DA; Wirshing WC; Marder SR
    J Clin Psychiatry; 2007 May; 68(5):705-10. PubMed ID: 17503979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
    Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of nicotine dependence and withdrawal symptoms on use of nicotine replacement therapy: Secondary analysis of a randomized controlled trial in primary care.
    Hollands GJ; Sutton S; Aveyard P
    J Subst Abuse Treat; 2022 Jan; 132():108591. PubMed ID: 34391588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.